Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials

BioDrugs 2026 Open access

Read full text
Authors: Z Ran, Yuehua Chen, Yinglei Miao, Yufang Wang, Xia Gao, J Zhong, Xueli Ding, Chengdang Wang, Xiaolan Zhang, Yijuan Ding, Naizhong Hu, Dan Tang
+3 more Jiao Yu, Chenxi Qian, Jun Shen
DOI: 10.1007/s40259-026-00793-x
Cited by: 1

Fields of Study & Subjects

Inflammatory Bowel Disease Microscopic Colitis Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
BioDrugs
Publisher
Springer Science and Business Media LLC
Volume
40
Issue
4
Pages
759–761
Publication date
1 July 2026
Language
EN